The virologist, awarded for his part in the discovery of the hepatitis C virus, has helped save the lives of millions of people Charles Rice, Nobel Prize winner in Medicine: ‘It’s a crime that a drug exists that could cure everyone yet not has… https://t.co/csnnWAvbKM
Had an incredible conversation with the virologist and @NobelPrize winner Charles Rice at #INGM in Milan. Truly inspiring to share our project on #TPD of #viruses and engage in such stimulating discussions with such a brilliant scientist!
The @RiceLaboratory has created the first mouse model that closely mirrors what happens when people with hepatitis C develop liver cancer, allowing scientists to study how liver virus infection leads to cancer as well as to test treatments.
🔗: https://t.co/PFA29AOM8b
This #PostdocAppreciationWeek, we celebrate postdocs at Rockefeller and beyond! In these short Q&As, we invite you to meet a few of them, hear about their work, and get a glimpse of the interests and experiences that inspire them outside the lab. https://t.co/2In93i1KKK
The latest issue of our research magazine Seek is out! Explore groundbreaking research on infectious disease, how AI is supercharging biomedical sciences, technology that’s changing how scientists view the brain, and more.
Read the full issue here: https://t.co/OtuOg3qQUa
We are deeply saddened to share that our friend and colleague Jim Hudspeth passed away on Saturday. We will remember and continue to be inspired by Jim’s integrity, his humility, and his unwavering commitment to discovery. https://t.co/80BMnDzriL
In this Q&A with @NatureSMB, @RiceLaboratory and Yael David of @MSKCancerCenter comment on new work that advances the molecular understanding of and, potentially, the clinical arsenal against infection with Hepatitis B virus. #WorldHepatitisDay
https://t.co/jBqPMexWGT
New publication out today in @natBME 🎉led by @zsinger JPabon demonstrating engineered bacteria launch and control a virus. A very cool cooperative microbial strategy for cancer therapy. Congrats to all! in collab with @RiceLaboratory
https://t.co/F8DfJvwKs9
Alexander Lercher of the @RiceLaboratory is a @CytokineSociety Young Investigator! He works on how past inflammatory events can result in durable antigen-independent innate immunity, enabling cross-protection against heterologous pathogens. Congrats! https://t.co/NFecNAPHQG
A recent study from @WeingartenShira, a former postdoc in the @RiceLaboratory, revealed 4,208 previously unknown proteins that are made by viruses such as influenza and H.I.V. using a new technique called massively parallel ribosome profiling. https://t.co/vXP4ip2I5x
New issue online! Cover depicts work from Charles Rice, Alexander Lercher & co. showing that antiviral innate immune memory in alveolar macrophages after SARS-CoV-2 infection ameliorates disease caused by a secondary unrelated pathogen. Image credit: Jessica Johnson @RiceLaboratory@alex_lercher https://t.co/Tx0Csyp02f
New issue online! Cover depicts work from Charles Rice, Alexander Lercher & co. showing that antiviral innate immune memory in alveolar macrophages after SARS-CoV-2 infection ameliorates disease caused by a secondary unrelated pathogen. Image credit: Jessica Johnson @RiceLaboratory@alex_lercher https://t.co/Tx0Csyp02f
In this video from our #OralHistoryProject, @NobelPrize laureate Charlie Rice (@RiceLaboratory) tells the story of his life and work. He describes how he came to study hepatitis C and the unexpected difficulty of developing a replication system. https://t.co/udmaXULZBc
Check out our latest paper published in @PLOSBiology, “A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist.” https://t.co/r5qmv1W1fH
🧵1/10
New findings on how past viral respiratory infections affect future infections with non-related viruses from the @RiceLaboratory could lead to therapies capable of boosting general antiviral immunity. #RockefellerScience https://t.co/H4zdJv0FPW
New findings on how past viral respiratory infections affect future infections with non-related viruses from the @RiceLaboratory could lead to therapies capable of boosting general antiviral immunity. #RockefellerScience https://t.co/H4zdJv0FPW